Pathway‐level mutational signatures predict breast cancer outcomes and reveal therapeutic targets
We assembled a comprehensive database of breast cancer samples and used this cohort to identify cancer-specific disruptive mutation signatures linked to altered survival outcomes.
Authors
- Balázs Győrffy (ORCID: https://orcid.org/0000-0002-5772-3766)
- Máté Posta
Institutions
- Semmelweis University (HU)
- University of Pecs (HU)
- HUN-REN Research Centre for Natural Sciences (HU)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1111/bph.70215
- Citations
- 26
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 24.34